Details of the Drug

General Information of Drug (ID: DMTTBQA)

Drug Name

RTX-134

Indication

Disease Entry	ICD 11	Status	REF
Phenylketonuria	5C50.0	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04110496) A Phase 1b Open-Label Single Dose Safety, Tolerability, and Pharmacokinetics Study of RTX-134 in Adults With Phenylketonuria. U.S.National Institutes of Health.